Le Lézard
Classified in: Health, Business, Covid-19 virus
Subject: CXP

Independence purchases corporate headquarters building at 1901 Market St.


PHILADELPHIA, June 30, 2020 /PRNewswire/ -- Independence Health Group ("Independence") today announced that it has completed the purchase of its corporate headquarters located at 1901 Market Street in Center City Philadelphia. The purchase builds upon Independence's ongoing commitment to the Greater Philadelphia region and continued investment in the West Market Street neighborhood. In addition to 1901 Market Street, Independence's Center City campus includes a leased state-of-the-art customer service call center at 1900 Market Street and Independence LIVE, an award-winning customer experience center at 1919 Market Street, which connects to the company's headquarters via a courtyard that is open to the community.

"The purchase of our headquarters at 1901 Market Street is a special moment for our company. More importantly, it signifies our long-term commitment to this neighborhood, the City of Philadelphia and to the amazing people who live and work here," said Independence Health Group CEO Daniel J. Hilferty during a ceremony at Independence headquarters. "This building is the cornerstone of our Center City campus, which is dedicated to the health and well-being of our associates, members, and our entire community. As we navigate the challenges of returning to a new normal amid COVID-19, our commitment remains as strong as ever."

Construction of 1901 Market Street began in 1987, specifically for Independence, and occupancy began in 1989. The building spans approximately 800,000 square feet, consists of 45 floors and occupies three quarters of an acre along the bustling West Market Street corridor. It is the eighth tallest office tower in Philadelphia and houses nearly 2,500 Independence associates.

Over the last decade, Independence reinvested in the building, named for former Independence CEO G. Fred DiBona, Jr., through key renovations and improvements, including the opening of The Center for Innovation, the Joseph A. Frick Training and Conference Center, an expanded cafeteria, a recently renovated associate fitness center, a revamped lobby, modernized workspaces on all floors, and updated building mechanicals and controls to improve overall efficiency. The building received the U.S. Environmental Protection Agency's ENERGY STAR certification for the past five years in a row, receiving a score of 84 in 2019.

"We are always looking for strategic ways to invest in the growth and efficiency of our organization, to ultimately better serve our members and the community," said Gregory E. Deavens, Independence executive vice president, chief financial officer, and treasurer. "Our commitment to Philadelphia through the purchase of our corporate headquarters is both an important development for our company and a vote of confidence in the bright future of this region."

The building was acquired from Piedmont Realty Trust.

For more than 80 years, Independence has continued to serve the Greater Philadelphia region as a leading health care company and one of its largest employers.

Contact:   Laura Hanes
215-241-2736 (office)
215-910-0966 (cell)
[email protected]

ibx.com
@ibx (Twitter)
@ibxfearless (Instagram)
Facebook.com/ibx

 

SOURCE Independence Blue Cross


These press releases may also interest you

at 17:48
On Wednesday, April 17, the San Joaquin Valley Health Fund (SJVHF) launched "Equity on the Road" a multi-city series of community town halls to deepen local understanding of state issues and to advocate for more resources in the San Joaquin Valley....

at 17:44
The Honourable Mark Holland, Minister of Health, will host an event at the University of Waterloo to highlight the federal budget's investments to support students. The Minister will be joined by Bryan May, Parliamentary Secretary to the Minister of...

at 17:31
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...

at 17:00
Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that it has closed a non-brokered private...

at 16:46
Darling Ingredients Inc. announced today that it will host a conference call on Thursday, April 25, 2024, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss first quarter 2024 financial results, which will be released earlier that day, and...

at 16:45
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic...



News published on and distributed by: